JAMIE WALLACE: Open Payments
NPI 1104608595 · OSWEGO, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,581 in 74 payments from 22 companies in 2025. Trend: 2023 $0 · 2024 $705 · 2025 $1,581
Food & beverage: $1,582
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $336 |
| AstraZeneca Pharmaceuticals LP | 9 | $154 |
| ALK-Abello, Inc | 6 | $143 |
| Corcept Therapeutics | 3 | $111 |
| GlaxoSmithKline, LLC. | 5 | $92 |
| Lilly USA, LLC | 4 | $83 |
| Otsuka America Pharmaceutical, Inc. | 3 | $82 |
| Exact Sciences Corporation | 3 | $76 |
| Amgen Inc. | 4 | $69 |
| Novo Nordisk Inc | 3 | $54 |
Products named: VRAYLAR, Odactra, REXULTI, Korlym, TRELEGY ELLIPTA, AIRSUPRA, JARDIANCE, The Cologuard Plus Collection Kit.
Industry payments across NY — which companies pay providers there.
